Jørgensen, Caroline Kamp http://orcid.org/0000-0002-7756-4694
Juul, Sophie
Siddiqui, Faiza
Horowitz, Mark Abie
Moncrieff, Joanna
Munkholm, Klaus
Hengartner, Michael Pascal
Kirsch, Irving
Gluud, Christian
Jakobsen, Janus Christian
Article History
Received: 8 March 2022
Accepted: 17 March 2023
First Online: 30 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: MAH declares that he is a Collaborating Investigator on the RELEASE trial of antidepressant tapering funded by the Medical Research Future Fund (MRFF) in Australia. He is co-founder and consultant to Outro Health, a digital clinic supporting people to stop unnecessary antidepressants. He has received honoraria for lectures to universities and hospital trusts in the UK and US. He is a member of the Critical Psychiatry Network and the International Institute of Psychiatric Drug Withdrawal. JM is a co-investigator on REDUCE (programme grant studying discontinuation of antidepressants) and Chief Investigator on RADAR (programme grant to explore antipsychotic reduction and discontinuation). JM has received lecture fees from Alberta Psychiatric Association, British Psychological Association, Université de Sherbrooke, University of Vancouver, Case Western Reserve University, and University of Basal. JM receives royalties from Palgrave Macmillan and PCCS Books for six books about psychiatric drugs. JM is a co-chair person of Critical Psychiatry Network and an unpaid board member of non-profit Council for Evidence-based Psychiatry. MPH receives royalties from Palgrave Macmillan for a book about antidepressants.